On May 26, 2011, the Federal Trade Commission announced it was undertaking a review of the so-called “Dot Com Disclosure Guidelines” it adopted in 2000 to provide insight to marketers using the internet.
My first reaction was positive. Knowing what the FTC thinks about disclosures is a good thing, right? And unlike the FDA, at least the FTC is willing to address important issues facing e-commerce. As reported in an earlier column, the Food and Drug Administration has had deaf ears in response to Pharma’s request for advice when marketing on social media.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
